GSK126

CAS No. 1346574-57-9

GSK126 ( GSK2816126; GSK-2816126; GSK 2816126 )

Catalog No. M11403 CAS No. 1346574-57-9

GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 81 In Stock
25MG 139 In Stock
50MG 215 In Stock
100MG 331 In Stock
200MG 431 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK126
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM.
  • Description
    GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM, >1000-fold selective for EZH2 over 20 other human methyltransferases.
  • Synonyms
    GSK2816126; GSK-2816126; GSK 2816126
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    EZH2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1346574-57-9
  • Formula Weight
    526.67
  • Molecular Formula
    C31H38N6O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 3 mg/mL warmed (5.69 mM)
  • SMILES
    O=C(C1=CC(C2=CC=C(N3CCNCC3)N=C2)=CC4=C1C(C)=CN4[C@@H](C)CC)NCC5=C(C)C=C(C)NC5=O
  • Chemical Name
    (S)-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.McCabe MT, et al. Nature. 2012, 492(7427), 108-112.
molnova catalog
related products
  • PFI-2

    A first-in-class, potent and selective inhibitor of SETD7 methyltransferase with Ki app/IC50 of 0.33/2 nM.

  • MI-1481

    MI-1481 (MI1481) is a highly potent inhibitor of the menin-MLL1 interaction with IC50 of 3.6 nM.

  • UNC0379 trifluoroace...

    UNC0379 is a selective, +N2106:AC2106substrate-competitive inhibitor of lysine methyltransferase SETD8 with IC50 of 7.3 uM.